What the Vaping Lung Injury Outbreak Taught Us About Causation

In 2019, thousands of mostly young people arrived in emergency rooms with a severe lung injury that had no name. Within months investigators had a prime suspect, and the way they built that case is a compact lesson in how causation is established. The decisive evidence did not come from counting how many patients vaped; it came from sampling fluid deep in the lungs, where vitamin E acetate appeared in 48 of 51 patients across 16 states and in none of 99 healthy comparison participants, as Blount and colleagues reported in the New England Journal of Medicine. That contrast, reinforced by biological plausibility and consistency across the country, is what moved the story from association toward cause.

The outbreak, briefly

The condition earned an acronym, EVALI, for e-cigarette or vaping product use associated lung injury. By mid-January 2020 the CDC counted 2,668 hospitalized cases, and the final tally reached 2,807 hospitalizations and 68 deaths before formal national reporting ended in February 2020. Most patients were young, with a median age around 24, and male, and the large majority, 82 percent in the CDC nationwide summary, reported using tetrahydrocannabinol (THC) containing products. Cases peaked in September 2019 and then fell sharply.

Why counting cases is not enough

Most patients reported THC use, but "most patients used X" is a weak claim standing alone. Vaping was common among young adults; survey almost any group of them and you will find plenty who vape. To argue that a specific ingredient injured the lung, you need more than an overlap between exposure and illness. You have to rule out the possibility that the link is coincidence, a reflection of who happens to vape, or a marker for some other item riding along in the same supply chain. Association is where an investigation starts, not where it ends.

Going to the tissue

Investigators then did something field epidemiology often cannot. They sampled the organ that was actually injured. Bronchoalveolar lavage washes sterile saline through a lung segment and recovers what is sitting in the air spaces. The first CDC report, published in November 2019, found vitamin E acetate in all 29 patient samples tested, while medium chain triglyceride oil, plant oils, petroleum distillates, and terpenes came back below detection. The larger NEJM study extended the work to 51 patients: vitamin E acetate in 94 percent, THC or its metabolites in most, and almost nothing else on the priority toxicant list.

The comparison group did the heavy lifting

The finding that mattered most was the negative one. Vitamin E acetate appeared in zero of 99 healthy comparators, a group that included nonusers, e-cigarette users, and cigarette smokers. A chemical present in nearly every patient and in none of the controls is showing specificity, one of the oldest signals epidemiologists look for. Without that comparison group, 48 positives would be a striking number with no yardstick. With it, the number becomes an argument, because the only way to know a finding is abnormal is to see what normal looks like.

How a causal case is assembled

No single result proves cause. What persuades is convergence, the kind of reasoning Austin Bradford Hill catalogued in 1965. Strength and specificity here were high: the toxicant was in the lungs of almost all patients and none of the controls. Consistency held, because the pattern repeated across geographically diverse states, which argued against a single local contaminant. Biological plausibility fit, because vitamin E acetate is oily and viscous at body temperature and can interfere with pulmonary surfactant, a coherent mechanism for diffuse lung injury. Temporality and reversibility followed, because as the compound was flagged and pulled from many illicit THC products, and as public warnings spread, cases declined. Any one of these could be explained away. Together they are hard to dismiss.

What careful investigators still would not say

The most instructive part is the hedge. Even while describing vitamin E acetate as strongly linked to the outbreak, the CDC wrote that evidence was "not sufficient to rule out the contribution of other chemicals of concern," in either THC or non-THC products. That caution is discipline, not weakness. A minority of patients reported nicotine only use, the lung is exposed to many substances at once, and "strongly linked" is a deliberately narrower claim than "sole cause." Good outbreak science names its prime suspect without pretending the file is closed.

Why this travels beyond vaping

The template repeats across medicine. Establish the exposure, find the agent at the site of injury, compare against people who do not have the disease, check whether the mechanism makes biological sense, and watch what happens when the exposure is removed. It is the same logic that identified occupational lung diseases and that underlies modern drug safety signals. This piece is educational and not medical advice, but the reasoning is worth carrying. When you next hear that something is "linked" to a harm, ask whether anyone has found it at the scene, whether there was a comparison group, and whether the story held up once the exposure went away.